Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes
Tatyana Kushner, Marina Serper, David E. Kaplan
Journal of Hepatology (2015) Vol. 63, Iss. 3, pp. 586-592
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Marc G. Ghany, Timothy R. Morgan
Hepatology (2019) Vol. 71, Iss. 2, pp. 686-721
Open Access | Times Cited: 861
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
Alexander Stockdale, Benno Kreuels, Marc Henrion, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 523-532
Open Access | Times Cited: 498
The hepatitis delta virus: Replication and pathogenesis
Camille Sureau, Francesco Negro
Journal of Hepatology (2016) Vol. 64, Iss. 1, pp. S102-S116
Open Access | Times Cited: 243
EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 132
The changing context of hepatitis D
Mario Rizzetto, Saeed Hamid, F. Negro
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1200-1211
Open Access | Times Cited: 126
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Florian A. Lempp, Yi Ni, Stephan Urban
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 13, Iss. 10, pp. 580-589
Closed Access | Times Cited: 143
Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
Ping An, Jinghang Xu, Yanyan Yu, et al.
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 140
Viral hepatitis and hepatocellular carcinoma: etiology and management
Philippe J. Zamor, Andrew S. deLemos, Mark W. Russo
Journal of Gastrointestinal Oncology (2017) Vol. 8, Iss. 2, pp. 229-242
Open Access | Times Cited: 138
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients
Charles Béguelin, Darius Moradpour, Roland Sahli, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 2, pp. 297-303
Open Access | Times Cited: 122
Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016
Eshan U. Patel, Chloe L. Thio, Denali Boon, et al.
Clinical Infectious Diseases (2019) Vol. 69, Iss. 4, pp. 709-712
Open Access | Times Cited: 122
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis
Alexander Stockdale, Mas Chaponda, Apostolos Beloukas, et al.
The Lancet Global Health (2017) Vol. 5, Iss. 10, pp. e992-e1003
Open Access | Times Cited: 120
A review on hepatitis D: From virology to new therapies
Nathalie Mentha, Sophie Clément, Francesco Negro, et al.
Journal of Advanced Research (2019) Vol. 17, pp. 3-15
Open Access | Times Cited: 104
Long‐Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver‐Related Outcomes
Habiba Kamal, Gabriel Westman, Karolin Falconer, et al.
Hepatology (2020) Vol. 72, Iss. 4, pp. 1177-1190
Open Access | Times Cited: 99
Pathogenesis of and New Therapies for Hepatitis D
Christopher Koh, Theo Heller, Jeffrey S. Glenn
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 461-476.e1
Open Access | Times Cited: 98
A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus–infected mongolians
Xiaohua Chen, Odgerel Oidovsambuu, Ping Liu, et al.
Hepatology (2016) Vol. 66, Iss. 6, pp. 1739-1749
Open Access | Times Cited: 90
Hepatitis D
Francesco Negro, Anna S. Lok
JAMA (2023) Vol. 330, Iss. 24, pp. 2376-2376
Closed Access | Times Cited: 41
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
Devin Razavi‐Shearer, Hannah Child, K. Razavi-Shearer, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 232-242
Open Access | Times Cited: 36
Diagnosis and Management of Hepatitis Delta Virus Infection
Calvin Pan, Robert G. Gish, Ira M. Jacobson, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 8, pp. 3237-3248
Open Access | Times Cited: 23
Association of hepatitis delta virus with liver morbidity and mortality: A systematic literature review and meta-analysis
Robert G. Gish, Robert J. Wong, Gian Luca Di Tanna, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1129-1140
Open Access | Times Cited: 23
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 10
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, et al.
Cancer Letters (2024) Vol. 597, pp. 217061-217061
Closed Access | Times Cited: 10
Low coverage of hepatitis D virus testing in individuals with hepatitis B virus and HIV, the Netherlands, 2000 to 2022
Anders Boyd, Colette Smit, Annemiek A. van der Eijk, et al.
Eurosurveillance (2025) Vol. 30, Iss. 7
Open Access | Times Cited: 1
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Marc Puigvehí, Carlos Moctezuma‐Velázquez, Augusto Villanueva, et al.
JHEP Reports (2019) Vol. 1, Iss. 2, pp. 120-130
Open Access | Times Cited: 66
Long‐term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia
Adriana Palom, Sergio Rodríguez‐Tajes, C.A. Navascués, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 51, Iss. 1, pp. 158-166
Closed Access | Times Cited: 65
Risk of hepatocellular carcinoma in hepatitis B and D virus co‐infected patients: A systematic review and meta‐analysis of longitudinal studies
Habiba Kamal, Romina Fornes, Johanna Simin, et al.
Journal of Viral Hepatitis (2021) Vol. 28, Iss. 10, pp. 1431-1442
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top